Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Olga Grishina"'
Autor:
Johanna Thomas, Usama-Ur Rehman, Helena Bresser, Olga Grishina, Dietmar Pfeifer, Etienne Sollier, Konstanze Döhner, Christoph Plass, Heiko Becker, Claudia Schmoor, Maike de Wit, Michael Lübbert
Publikováno v:
Clinical Epigenetics, Vol 16, Iss 1, Pp 1-5 (2024)
Abstract DNA-hypomethylating agents (HMAs) induce notable remission rates in AML/MDS patients with TP53 mutations; however, secondary resistance often develops rapidly. In the DECIDER trial (NCT00867672), elderly AML patients (also those with adverse
Externí odkaz:
https://doaj.org/article/1be44a233b44476594d325965bb4fbac
Autor:
Nora Rebeka Javorniczky, Olga Grishina, Inga Hund, Milena Pantic, Dietmar Pfeifer, Claudia Schmoor, Johanna Thomas, Justus Duyster, Heiko Becker, Michael Lübbert
Publikováno v:
Clinical Epigenetics, Vol 15, Iss 1, Pp 1-5 (2023)
Abstract Elderly patients with AML ineligible for induction have a dismal prognosis; hence disease stabilization is a primary treatment goal. This case of a 75-year-old patient with secondary AML receiving the combination of decitabine and ATRA (with
Externí odkaz:
https://doaj.org/article/6085df4c75ec4101b2942e2480228aaa
Autor:
Christoph Rummelt, Olga Grishina, Claudia Schmoor, Martina Crysandt, Michael Heuser, Katharina S. Götze, Richard F. Schlenk, Konstanze Döhner, Helmut R. Salih, Gerhard Heil, Carsten Müller-Tidow, Wolfram Brugger, Andrea Kündgen, Maike de Wit, Aristoteles Giagounidis, Sebastian Scholl, Andreas Neubauer, Jürgen Krauter, Gesine Bug, Haifa Kathrin Al-Ali, Ralph Wäsch, Heiko Becker, Annette M. May, Justus Duyster, Björn Hackanson, Arnold Ganser, Hartmut Döhner, Michael Lübbert
Publikováno v:
Haematologica, Vol 108, Iss 8 (2023)
Externí odkaz:
https://doaj.org/article/3448ad0c720c4bd583057eb97a440fb5
Autor:
Nikolas von Bubnoff, Gabriele Ihorst, Olga Grishina, Nadine Röthling, Hartmut Bertz, Justus Duyster, Jürgen Finke, Robert Zeiser
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
Abstract Background Graft-versus-Host Disease (GvHD) causes significant morbidity and mortality in patients after allogeneic stem cell transplantation. Donor T-cells cause inflammation and tissue damage in GvHD target organs such as liver, gut and sk
Externí odkaz:
https://doaj.org/article/98052a2f89ed4d34a9b8cc9c0c77c2cf
Autor:
Iryna Pototska, Olga Grishina
Publikováno v:
Психологічний Часопис, Vol 14, Iss 4, Pp 138-148 (2018)
Досліджено фактори, що сприяють виникненню суїцидальних думок серед робітниць комерційного сексу. Емпіричне дослідження проводилось з
Externí odkaz:
https://doaj.org/article/32638f886c204272826023c9aa35f914
Publikováno v:
EURINT, Vol 4, Pp 149-167 (2017)
Amid activation of Islamic State (IS) recruiters among European and Russian youth, society is more and more concerned about the efficiency of contemporary higher education humanistic function. The article identifies one of the relevant areas in study
Externí odkaz:
https://doaj.org/article/edae5b6285f447908930273640f2116e
Autor:
Johannes M. Waldschmidt, Alexander Keller, Gabriele Ihorst, Olga Grishina, Stefan Müller, Dagmar Wider, Anna V. Frey, Kristina King, Roman Simon, Annette May, Pierfrancesco Tassone, Justus Duyster, Manfred Jung, Noopur Raje, Ralph Wäsch, Monika Engelhardt
Publikováno v:
Haematologica, Vol 103, Iss 10 (2018)
Externí odkaz:
https://doaj.org/article/18b36841790c402eb18446081d8c31cc
Autor:
Jürgen Finke, Claudia Schmoor, Matthias Stelljes, Andreas Burchert, Peter Dreger, Ute Hegenbart, Eva-Maria Wagner-Drouet, Martin Bornhäuser, Kristina Sohlbach, Natalie Schub, Christian Reicherts, Guido Kobbe, Bertram Glass, Hartmut Bertz, Olga Grishina
Publikováno v:
Bone Marrow Transplantation. 57:1664-1670
Therapeutic options for patients with AML relapsing after allogeneic HCT range from chemotherapy or hypomethylating agents with or without donor lymphocyte infusions to a 2nd allogeneic HCT. Available data are based on retrospective single center or
Autor:
Michael Lübbert, Christoph Plass, Dieter Weichenhan, Dietmar Pfeifer, Olga Grishina, Nadja Blagitko-Dorfs, Ruth Meier, Ulrike Bönisch, Lea Gutenkunst, Dennis Zimmer, Julia Stomper, Bettina Berberich, Björn A. Grüning, Julia Schüler, Gabriele Greve
Supplementary Information: Supplementary Figures 1-11, Supplementary Figure Legends, Supplementary Tables 1-4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49dc5821022c16703878c9fcebb89670
https://doi.org/10.1158/0008-5472.22426905.v1
https://doi.org/10.1158/0008-5472.22426905.v1
Autor:
Michael Lübbert, Christoph Plass, Dieter Weichenhan, Dietmar Pfeifer, Olga Grishina, Nadja Blagitko-Dorfs, Ruth Meier, Ulrike Bönisch, Lea Gutenkunst, Dennis Zimmer, Julia Stomper, Bettina Berberich, Björn A. Grüning, Julia Schüler, Gabriele Greve
Hypomethylating agents (HMA) have become the backbone of nonintensive acute myeloid leukemia/myelodysplastic syndrome (AML/MDS) treatment, also by virtue of their activity in patients with adverse genetics, for example, monosomal karyotypes, often wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c6fdbf94468184f59ef641665a3b356
https://doi.org/10.1158/0008-5472.c.6512490.v1
https://doi.org/10.1158/0008-5472.c.6512490.v1